Table 2 Medications for the study group
| Â | Age Groups | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Â | 20-29 | 30-39 | 40-49 | 50-59 | 60-69 | >70 | ||||||
| Â | Male | Female | Male | Female | Male | Female | Male | Female | Male | Female | Male | Female |
|  | (n = 92) | (n = 117) | (n = 54) | (n = 44) | (n = 66) | (n = 80) | (n = 39) | (n = 57) | (n = 61) | (n = 56) | (n = 57) | (n = 54) |
Aspirin (%) | 0.0 | 0.0 | 0.0 | 0.0 | 3.0 | 1.3 | 7.7 | 7.0 | 24.6 | 10.7 | 28.1 | 31.5 |
Beta Blocker (%) | 0.0 | 0.0 | 1.9 | 2.3 | 3.0 | 1.3 | 7.7 | 7.0 | 11.5 | 14.3 | 24.6 | 20.4 |
Calcium Channel Blocker (%) | 0.0 | 0.0 | 1.9 | 0.0 | 4.5 | 3.8 | 10.3 | 3.5 | 23.0 | 16.1 | 29.8 | 33.3 |
ACE inhibitor/ARB (%) | 0.0 | 0.0 | 3.7 | 0.0 | 7.6 | 11.3 | 15.4 | 14.0 | 36.1 | 37.5 | 40.4 | 40.7 |
Diuretic (%) | 0.0 | 0.0 | 0.0 | 2.3 | 3.0 | 2.5 | 2.6 | 10.5 | 13.1 | 16.1 | 22.8 | 27.8 |
Statin (%) | 0.0 | 0.0 | 1.9 | 0.0 | 0.0 | 1.3 | 10.3 | 3.5 | 21.3 | 14.3 | 28.1 | 27.8 |
HRT (%) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.8 | 0.0 | 3.6 | 0.0 | 3.7 |
Taking Medication (%) | 0.0 | 0.0 | 5.6 | 2.3 | 10.6 | 12.5 | 28.2 | 29.8 | 65.6 | 58.9 | 80.7 | 75.9 |